Effect of low dose continuous corticosteroid therapy in men with antisperm antibodies on spermatozoal quality and conception rate.
The use of steroids for treating male immunological infertility is controversial. The effect of low dose prednisolone on sperm quality in men with antisperm antibodies and the conception rate, was evaluated in 40 men and their wives. Significant circulating antisperm antibodies were detected by immunofluorescence technique. Prednisolone (5 mg) was administered orally, daily for 3-6 months in men with significant antisperm antibodies. Another group of 37 men with significant antisperm antibodies, formed the control group. Both groups had initial pre- and post therapy semen analysis and hypoosmotic swelling (HOS) test. They were followed up for 12-18 months and the pregnancy outcome documented. There were significant improvement in sperm motility and hypoosmatic swelling test with therapy (P < 0.01, P > 0.05) of 13 and 15%, respectively. The pregnancy rate of 20% was much greater than 5% in the control group (P < 0.01). There were no side effects of prednisolone. Low dose prednisolone is useful in Antisperm antibody associated infertility, by improving the sperm quality and giving rise to pregnancies.
Omu
A E
AE
Department of Obstetrics and Gynaecology, Faculty of Medicine Kuwait University, Maternity Hospital Kuwait, Kuwait.
al-Qattan
F
F
Abdul Hamada
B
B
D000328:Adult; D001323:Autoantibodies / Q000187:drug effects / Q000276:immunology; D015331:Cohort Studies; D005260:Female; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007248:Infertility, Male / Q000188:drug therapy* / Q000276:immunology; D008297:Male; D011239:Prednisolone / Q000494:pharmacology* / Q000627:therapeutic use; D011247:Pregnancy; D018873:Pregnancy Rate; D012661:Semen / Q000166:cytology / Q000187:drug effects; D013076:Sperm Count / Q000187:drug effects; D013081:Sperm Motility / Q000187:drug effects / Q000502:physiology; D013094:Spermatozoa / Q000187:drug effects* / Q000276:immunology; D016896:Treatment Outcome
D001323:Autoantibodies; D005938:Glucocorticoids; D011239:Prednisolone